Oakbrook Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$23.6M |
| 2 |
Comcast
CMCSA
|
+$15.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$15M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$14.1M |
| 5 |
Amgen
AMGN
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$25.1M |
| 2 |
UnitedHealth
UNH
|
+$24.3M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$18.8M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$18.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Healthcare | 15.43% |
| 3 | Technology | 14.16% |
| 4 | Consumer Staples | 10.28% |
| 5 | Energy | 9.99% |
Similar funds
Oakbrook Investments's Q1 2014 Portfolio in Review
As of Q1 2014, Oakbrook Investments held 659 positions worth $3.17B, down 12% from $3.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Oakbrook Investments withdrew a net $475M in Q1 2014, closing 67 positions and reducing 444 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $18.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Oakbrook Investments opened a new position in McCormick & Company Non-Voting worth $16M.
- Oakbrook Investments's largest Q1 2014 buy was McCormick & Company Non-Voting: 445,890 shares worth $16M.
- Oakbrook Investments added most to ExxonMobil in Q1 2014, an estimated $23.6M increase.
- Oakbrook Investments's biggest Q1 2014 reduction was Chevron, cutting an estimated $25.1M.
- Oakbrook Investments fully exited Express Scripts Holding Company in Q1 2014, selling an estimated $18.4M.
- Oakbrook Investments's ten largest holdings make up 19% of its $3.17B portfolio in Q1 2014.
- Oakbrook Investments opened 65 new positions and closed 67 in Q1 2014.
- Oakbrook Investments's portfolio value fell 12% quarter-over-quarter to $3.17B.
Based on Oakbrook Investments's 13F filing for Q1 2014, filed 17 Apr 2014.